We are part of the National Institute of

Biomedical Innovation, Health, and Nutrition based in Japan.

We carry out bioinformatics and computational biology research

into drug discovery and development with special emphasis on

early-stage target discovery and toxicity prediction.

In the Bioinformatics and Computational Biology Group at the NIBIOHN,

we carry out research into drug discovery and development

with special emphasis on data integration,

target discovery and safety assessment.

Our research involves both the analysis of real-life experimental data

and the development of novel computational techniques,

aiming to establish new systems and approaches to drug discovery.

Our research involves the development of novel computational techniques.

We are actively engaged in software development.